Header Logo

Connection

AZIZ SHAIBANI to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications AZIZ SHAIBANI has written about Antibodies, Monoclonal, Humanized.
AZIZ SHAIBANI
Connection Strength
0.168
Antibodies, Monoclonal, Humanized
  1. Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. Neurology. 2021 03 23; 96(12):e1595-e1607.
    View in: PubMed
    Score: 0.088
  2. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. Lancet Neurol. 2019 09; 18(9):834-844.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.